Comparison of clinical, pathological and genomic characteristics between Lynch and non-Lynch patients with MMRd endometrial carcinoma.

BMC Cancer · 2026 · PMC13134137 · PMID 41872806

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In patients with MMRd EC, those with MLH1 promoter methylation showed a trend toward inferior PFS compared with the unmethylated group, although the difference was not statistically significant ( P = 0.139).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.